Citations 1

Ruxolitinib safety experience in the polycythemia vera clinical trial program.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e18082-e18082

10.1200/jco.2015.33.15_suppl.e18082